HÁJEK, Roman, Marta KREJČÍ, Andrea KŘIVANOVÁ, Luděk POUR, Zdeněk ADAM, Lenka ZAHRADOVÁ, E. VETEŠNÍKOVÁ, Jiří MAYER and Jiří VORLÍČEK. Salvage treatment with Melphalan 100 mg/m2 in fulminant progression of multiple myeloma. In Hematologica/The hematology Journal, 2007; Vol.92, suppl.1. 2007. ISSN 0390-6078.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Salvage treatment with Melphalan 100 mg/m2 in fulminant progression of multiple myeloma
Name in Czech Léčba PGMM
Authors HÁJEK, Roman, Marta KREJČÍ, Andrea KŘIVANOVÁ, Luděk POUR, Zdeněk ADAM, Lenka ZAHRADOVÁ, E. VETEŠNÍKOVÁ, Jiří MAYER and Jiří VORLÍČEK.
Edition Hematologica/The hematology Journal, 2007; Vol.92, suppl.1, 2007.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30200 3.2 Clinical medicine
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 5.516
Organization unit Faculty of Medicine
ISSN 0390-6078
UT WoS 000247176900264
Keywords in English multiple myeloma
Tags multiple myeloma
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Roman Hájek, CSc., učo 33302. Changed: 10/2/2010 14:50.
Abstract
This presentation was focused on salvage treatment with Melphalan 100 mg/m2 in fulminant progression of multiple myeloma.
Abstract (in Czech)
Prezentace byla zaměřena na možnosti léčby PGMM.
PrintDisplayed: 28/6/2024 15:27